Home » Stocks » VERA

Vera Therapeutics, Inc. (VERA)

Stock Price: $15.84 USD 1.59 (11.16%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
After-hours: $15.69 -0.15 (-0.95%) Jun 22, 7:12 PM
Market Cap 324.39M
Revenue (ttm) n/a
Net Income (ttm) -53.41M
Shares Out 20.48M
EPS (ttm) -2.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 22
Last Price $15.84
Previous Close $14.25
Change ($) 1.59
Change (%) 11.16%
Day's Open 15.33
Day's Range 14.05 - 16.47
Day's Volume 21,698
52-Week Range 11.30 - 26.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative trea...

3 weeks ago - GlobeNewsWire

Vera Therapeutics Inc has priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds. The biotech will start trading on NAS...

1 month ago - Benzinga

SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments...

1 month ago - GlobeNewsWire

Vera Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

About VERA

Vera Therapeutics is a clinical stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Our lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. We are conducting a Phase 2b clinical trial of atac... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
May 14, 2021
CEO
Marshall Fordyce, M.D.
Employees
8
Stock Exchange
NASDAQ
Ticker Symbol
VERA
Full Company Profile

Financial Performance

Financial Statements